Literature DB >> 10918579

Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.

A Suzuki1, M Hayashida, T Ito, H Kawano, T Nakano, M Miura, K Akahane, K Shiraki.   

Abstract

Survivin is observed uniquely in tumor cells and developmental cells, which undergo either inappropriate or programmed cell growth. In the current study, we investigated the influence of Survivin on cell cycle. Overexpression of Survivin resulted in accelerated S phase shift, resistance to G1 arrest, and activated Cdk2/Cyclin E complex leading Rb phosphorylation. In addition, nuclear translocation of Survivin followed by an interaction with Cdk4 was detected. Interestingly, Survivin nuclear translocation coincided with S phase shift, and prevention of nuclear transport suppressed Survivin nuclear translocation and S phase shift. Further, we also observed that Survivin competitively interacted with the Cdk4/p16(INK4a) complex in a cell free system and in vivo. These results suggest that Survivin initiates the cell cycle entry as a result of nuclear translocation followed by an interaction with Cdk4.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918579     DOI: 10.1038/sj.onc.1203665

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  63 in total

Review 1.  The Survivin saga goes in vivo.

Authors:  J C Reed
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

2.  The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.

Authors:  Anjaiah Srirangam; Monica Milani; Ranjana Mitra; Zhijun Guo; Mariangellys Rodriguez; Hitesh Kathuria; Seiji Fukuda; Anthony Rizzardi; Stephen Schmechel; David G Skalnik; Louis M Pelus; David A Potter
Journal:  J Thorac Oncol       Date:  2011-04       Impact factor: 15.609

3.  Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.

Authors:  Pablo E Vivas-Mejia; Cristian Rodriguez-Aguayo; Hee-Dong Han; Mian M K Shahzad; Fatma Valiyeva; Mineko Shibayama; Arturo Chavez-Reyes; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Clin Cancer Res       Date:  2011-04-21       Impact factor: 12.531

4.  Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas.

Authors:  Hakhyun Ka; Joan S Hunt
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

5.  Carminomycin I is an apoptosis inducer that targets the Golgi complex in clear cell renal carcinoma cells.

Authors:  Girma M Woldemichael; Thomas J Turbyville; W Marston Linehan; James B McMahon
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

Review 6.  Nuclear or cytoplasmic expression of survivin: what is the significance?

Authors:  Fengzhi Li; Jie Yang; Nithya Ramnath; Milind M Javle; Dongfeng Tan
Journal:  Int J Cancer       Date:  2005-04-20       Impact factor: 7.396

7.  Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.

Authors:  Marcelo L Rodriguez-Puebla; Paula L Miliani de Marval; Margaret LaCava; David S Moons; Hiroaki Kiyokawa; Claudio J Conti
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex.

Authors:  Hacer Guvenc; Marat S Pavlyukov; Kaushal Joshi; Habibe Kurt; Yeshavanth K Banasavadi-Siddegowda; Ping Mao; Christopher Hong; Ryosuke Yamada; Chang-Hyuk Kwon; Deepak Bhasin; Somsundaram Chettiar; Gaspar Kitange; In-Hee Park; Jann N Sarkaria; Chenglong Li; Mihail I Shakhparonov; Ichiro Nakano
Journal:  Clin Cancer Res       Date:  2012-12-18       Impact factor: 12.531

9.  In vitro anti-cancer activity of chamaejasmenin B and neochamaejasmin C isolated from the root of Stellera chamaejasme L.

Authors:  Chong Zhang; Shuang-shuang Zhou; Lin-yi Feng; Da-yong Zhang; Neng-ming Lin; Li-huang Zhang; Jian-ping Pan; Jun-bo Wang; Jie Li
Journal:  Acta Pharmacol Sin       Date:  2012-12-10       Impact factor: 6.150

10.  Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles.

Authors:  Andrea Caporali; Elisabetta Pani; Anton J G Horrevoets; Nicolle Kraenkel; Atsuhiko Oikawa; Graciela B Sala-Newby; Marco Meloni; Brunella Cristofaro; Gallia Graiani; Aurelie S Leroyer; Chantal M Boulanger; Gaia Spinetti; Sung Ok Yoon; Paolo Madeddu; Costanza Emanueli
Journal:  Circ Res       Date:  2008-06-19       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.